Ironwood Pharmaceuticals, Inc.
Low-Dose Stable Formulations of Linaclotide
Last updated:
Abstract:
The present invention relates to stable pharmaceutical compositions comprising linaclotide or pharmaceutically acceptable salts thereof, as well as to various methods and processes for the preparation and use of the compositions.
Status:
Application
Type:
Utility
Filling date:
18 Oct 2021
Issue date:
3 Feb 2022